Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
XRP Price Prediction: AI Bots Push 13.9M Payments as Holders Turn to Pepeto Before a Run
-
Chainlink Price Prediction: LINK Eyes $18.40 Before Wall Street’s New York Summit, but Buyers Chase Pepeto
-
Best Crypto Presale: Another “I Almost Bought It” Story? AlphaPepe’s 500x Scenario Starts at $0.03335
-
Crypto News: Bitcoin Price Recovers $2K From Overnight Low While AlphaPepe’s 300x Bull Case Starts Before Listing
-
Pancreatic Ductal Adenocarcinoma Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
-
Marginal Zone Lymphoma Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight
-
NASH Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight
-
Non Alcoholic Fatty Liver Disease Clinical Trial Pipeline Gains Momentum: 90+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
-
Ocular Hypertension Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 50+ Leading Players Wheeling the Therapeutics Landscape
-
Mitsubishi Electric to Participate in COP31
-
UVJC Launches NovaJet, First Commercial System Built on Universal Vapor Jet Printing Platform
-
SEON Partners with Yuno to Expand Global Fraud Prevention and Identity Verification
-
Colt Silver to List on the TSX Venture Exchange Under the Symbol "COLT" on October 19, 2026
-
Relapsed/Refractory Acute Myeloid Leukemia Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 50+ Leading Players Wheeling the Therapeutics Landscape
-
Pulmonary Fibrosis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 110+ Leading Players Wheeling the Therapeutics Landscape
-
Refractory Multiple Myeloma Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight
-
EGFR Inhibitor Market Expected to Gain Momentum Through 2034, According to DelveInsight
-
Non-Hodgkin Lymphoma Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation – DelveInsight | Autolus, Genor Biopharma, AbbVie/ Genmab, AstraZeneca, Jiangsu Hengrui
-
OPPOLIA to Showcase Integrated Home Furnishing Solutions at the 140th Canton Fair
-
Type 2 Diabetes Market Set for Robust Growth Driven by Innovation and Pipeline Advances by 2036 – DelveInsight | Eli Lilly, Regor Pharma, AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences, MediciNo
-
Mantle Cell Lymphoma Market Forecast 2034: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight | PharmaEngine, Jiangsu Hansoh Pharmaceutical, Galapagos NV, Miltenyi Biomedicine
-
Diffuse Large B-cell Lymphoma Market Analysis 2034: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Genmab and AbbVie, Kite (Gilead Sciences), Denovo Biopharma
-
Excessive Daytime Sleepiness (EDS) Market Size, Share, Growth, Epidemiology and Forecast to 2036
-
Alzheimer’s Disease Market Outlook 2036: Growth Trends, Competitive Landscape, and Future Opportunities – DelveInsight | Alpha Cognition, Biogen, Eisai, Eli Lilly, Otsuka Pharma, Lundbeck, Suven L
-
Degenerative Disc Disease (DDD) Market Size, Share, Growth, Epidemiology and Forecast to 2036
-
Common Warts Market is Expected to Witness Growth by 2036 Owing to the Increasing Demand for Targeted and Immunotherapeutic Treatment Approaches | DelveInsight
-
Aplastic Anemia Market Size, Share, Growth, Epidemiology and Forecast to 2036
-
Homozygous Familial Hypercholesterolemia Market is Expected to Witness Growth by 2036 Owing to the Increasing Adoption of Novel Lipid-Lowering Therapies and RNA-Based Treatments | DelveInsight
-
Ensorcia Announces Agreement to Acquire Argentina Wildcats
-
Silver Pony Announces Strategic Flow-Through Offering
-
Prospect Ridge Announces First Tranche Closing of Critical Metals Flow-Through Unit Private Placement
-
GreenCore Solutions Corp. (GSC) Releases gtinfetch.ai -- the GTIN Resolver for AI Agents
-
Nurse-Founded Culinary & Cannabis Rebrands as Savor & Solace, Returns to Los Angeles With Three November Experiences
-
Pilates Addiction Hits 350 Licenses Sold as National Studio Rollout Shifts Into High Gear
-
Photoelectric Sensor Market to Reach USD 3.05 Billion by 2031, Driven by Industrial Automation and Smart Manufacturing
-
Plasma Fractionation Market to Reach USD 63.06 Billion by 2031, Driven by Rising Demand for Immunoglobulins and Plasma-Derived Therapies
-
/C O R R E C T I O N - Complex/
-
Argo Graphene Solutions Corp. Grants Incentive Stock Options
-
Asia Pacific AI Demand Drives Record Growth, Spending on Tech Services in Q3, ISG Index™ Shows
-
AI/ML Innovations Announces Completion of Share Issuance
-
Arnold Schwarzenegger and Senate Pro Tem Monique Limón team up with AB 32’s Authors to Mark the Law’s 20th Anniversary at the 2026 California Economic Summit
-
Optro Raises the Bar on Partner Investment with Growth Funding and Expanded Partner Tracks
-
Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity
-
Springs Rejuvenation Brings Stem Cell Exosome Therapy to 5 US Cities
-
Yorkton Equity Group Inc. Announces Unconditional Agreement to Sell Winton Terrace Property
-
CYPFER Announces Leadership Transition Under New Ownership by Apros Group
-
Wecom Fiber, Arizona Commerce Authority and Local Partners Celebrate Ribbon Cutting of Broadband Project in the Town of Parker
-
Paladin Energy Ltd: Quarterly Report for the period ending 30 September 2026
-
Round1 Opens World’s First YUU Japanese Food Hall in Ventura With 14 Celebrated Restaurants From Japan
-
Rithm Property Trust Schedules Third Quarter 2026 Earnings Release
